1. Home
  2. NXTC vs CVV Comparison

NXTC vs CVV Comparison

Compare NXTC & CVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextCure Inc.

NXTC

NextCure Inc.

SELL

Current Price

$6.83

Market Cap

24.8M

Sector

Health Care

ML Signal

SELL

Logo CVD Equipment Corporation

CVV

CVD Equipment Corporation

SELL

Current Price

$4.59

Market Cap

27.9M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
NXTC
CVV
Founded
2015
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
24.8M
27.9M
IPO Year
2019
2007

Fundamental Metrics

Financial Performance
Metric
NXTC
CVV
Price
$6.83
$4.59
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $20.00
N/A
AVG Volume (30 Days)
51.7K
★ 54.6K
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 17.86
EPS
N/A
★ 1.36
Revenue
$22,378,000.00
★ $41,128,639.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$3.35
Revenue Growth
N/A
★ 96.27
52 Week Low
$1.55
$2.96
52 Week High
$15.74
$9.10

Technical Indicators

Market Signals
Indicator
NXTC
CVV
Relative Strength Index (RSI) 54.35 60.15
Support Level $4.28 $3.65
Resistance Level $6.66 $4.97
Average True Range (ATR) 0.80 0.24
MACD 0.09 0.12
Stochastic Oscillator 69.35 89.78

Price Performance

Historical Comparison
NXTC
CVV

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company that is focused on advancing inventive medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies including antibody-drug conjugates. The company's product candidates include NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

About CVV CVD Equipment Corporation

CVD Equipment Corp designs, develops, and manufactures a broad range of equipment used to develop and produce materials and coatings for the aerospace, compound semiconductor, semiconductor, aerospace, battery energy storage markets as well as industrial applications, and research. It currently conducts its business through two reportable segments: CVD Equipment, which designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; and SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems. Its target markets are aerospace & defense and industrial, microelectronics / high power electronics, and EV battery materials / energy storage.

Share on Social Networks: